WebApr 13, 2024 · Actively observing the price movement in the last trading, the stock closed the session at $18.34, falling within a range of $17.93 and $19.21. The value of beta (5-year monthly) was 2.00. Referring to stock’s 52-week performance, its high was $25.69, and the low was $6.91. On the whole, PTGX has fluctuated by -26.52% over the past month. Top ... WebGet the latest Protagonist Therapeutics, Inc. (PTGX) stock news and headlines to help you in your trading and investing decisions.

PTGX Stock News PROTAGONIST THERAPEUTICS Stock Price …

WebLatest stock price today and the US's most active stock market forums. Protagonist Therapeutics (PTGX) stock price, charts, trades & the US's most popular discussion … WebApr 10, 2024 · Common Stock, par value $0.00001: PTGX: The Nasdaq Stock Market, LLC: ... (the "Common Stock"). The price to the public in this offering is $20.00 per share, and the Underwriters have agreed to purchase the shares from the Company pursuant to the Underwriting Agreement at a price of $18.80 per share. ... All news about PROTAGONIST … humanities intranet

Protagonist Therapeutics (PTGX) Price To Free Cash Flow - Zacks.com

Web2 days ago · Analyst Forecast. According to 12 analysts, the average rating for PTGX stock is "Buy." The 12-month stock price forecast is $34.88, which is an increase of 82.33% from … WebApr 10, 2024 · PTGX Complete Protagonist Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. WebApr 10, 2024 · To see how Protagonist Therapeutics Inc. stock has been performing in comparison to its peers in the industry, here are the numbers: PTGX stock’s performance was 2.50% in the latest trading, and -23.80% in the past year, while Pieris Pharmaceuticals Inc. (PIRS) has traded -11.36% on the day and positioned -74.84% lower than it was a year … hollerithallee 1 30419 hannover